Tolterodine tartrate
Tolterodine Tartrate is a prescription medication available as extended-release capsules (2 mg and 4 mg) for oral use. It works as a cholinergic muscarinic antagonist to treat symptoms of overactive bladder, such as frequent urination, urgency, and incontinence. Manufactured by Unichem Pharmaceuticals (USA), Inc., under ANDA216917. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Tolterodine Tartrate is a prescription medication available as extended-release capsules (2 mg and 4 mg) for oral use. It works as a cholinergic muscarinic antagonist to treat symptoms of overactive bladder, such as frequent urination, urgency, and incontinence. Manufactured by Unichem Pharmaceuticals (USA), Inc., under ANDA216917. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Tolterodine tartrate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Tolterodine tartrate — ANDA 079141 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079141"
}
]
|
| identifier | ANDA079141 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-safety",
"fda",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Tolterodine tartrate |
